Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Inagaki

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Molecular Therapy. Oncology|October 2, 2025
Design, development, and evaluation of gene therapeutics specific to KSHV-associated diseasesTomoki Inagaki, Jonna Magdallene Espera, Kang-Hsin Wang, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Studies on Gene Enhancer with KSHV mini-chromatinTomoki Inagaki, Ashish Kumar, Kang-Hsin Wang, et al.
Plos Pathogens|December 4, 2025
KSHV TR deletion episomes uncover enhancer-promoter dynamics in gene regulationTomoki Inagaki, Ashish Kumar, Kang-Hsin Wang, et al.
Plos Pathogens|November 7, 2023
KSHV vIL-6 enhances inflammatory responses by epigenetic reprogrammingTomoki Inagaki, Kang-Hsin Wang, Ashish Kumar, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
KSHV vIL-6 Enhances Inflammatory Responses by Epigenetic ReprogrammingTomoki Inagaki, Kang-Hsin Wang, Ashish Kumar, et al.
Cell Communication and Signaling : CCS|June 21, 2022
Epstein-Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infectionYoshitaka Sato, Masahiro Yaguchi, Yusuke Okuno, et al.
Frontiers in Microbiology|June 7, 2024
Corrigendum: Direct evidence of abortive lytic infection-mediated establishment of Epstein-Barr virus latency during B-cell infectionTomoki Inagaki, Yoshitaka Sato, Jumpei Ito, et al.
Frontiers in Microbiology|February 22, 2021
Direct Evidence of Abortive Lytic Infection-Mediated Establishment of Epstein-Barr Virus Latency During B-Cell InfectionTomoki Inagaki, Yoshitaka Sato, Jumpei Ito, et al.
Journal of Virology|February 1, 2019
S-Like-Phase Cyclin-Dependent Kinases Stabilize the Epstein-Barr Virus BDLF4 Protein To Temporally Control Late Gene TranscriptionYoshitaka Sato, Takahiro Watanabe, Chihiro Suzuki, et al.
Cell Chemical Biology|November 2, 2024
A LANA peptide inhibits tumor growth by inducing CHD4 protein cleavage and triggers cell deathHiroki Miura, Kang-Hsin Wang, Tomoki Inagaki, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Molecular Therapy. Oncology|October 2, 2025
Design, development, and evaluation of gene therapeutics specific to KSHV-associated diseasesTomoki Inagaki, Jonna Magdallene Espera, Kang-Hsin Wang, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Studies on Gene Enhancer with KSHV mini-chromatinTomoki Inagaki, Ashish Kumar, Kang-Hsin Wang, et al.
Plos Pathogens|December 4, 2025
KSHV TR deletion episomes uncover enhancer-promoter dynamics in gene regulationTomoki Inagaki, Ashish Kumar, Kang-Hsin Wang, et al.
Plos Pathogens|November 7, 2023
KSHV vIL-6 enhances inflammatory responses by epigenetic reprogrammingTomoki Inagaki, Kang-Hsin Wang, Ashish Kumar, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
KSHV vIL-6 Enhances Inflammatory Responses by Epigenetic ReprogrammingTomoki Inagaki, Kang-Hsin Wang, Ashish Kumar, et al.
Cell Communication and Signaling : CCS|June 21, 2022
Epstein-Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infectionYoshitaka Sato, Masahiro Yaguchi, Yusuke Okuno, et al.
Frontiers in Microbiology|June 7, 2024
Corrigendum: Direct evidence of abortive lytic infection-mediated establishment of Epstein-Barr virus latency during B-cell infectionTomoki Inagaki, Yoshitaka Sato, Jumpei Ito, et al.
Frontiers in Microbiology|February 22, 2021
Direct Evidence of Abortive Lytic Infection-Mediated Establishment of Epstein-Barr Virus Latency During B-Cell InfectionTomoki Inagaki, Yoshitaka Sato, Jumpei Ito, et al.
Journal of Virology|February 1, 2019
S-Like-Phase Cyclin-Dependent Kinases Stabilize the Epstein-Barr Virus BDLF4 Protein To Temporally Control Late Gene TranscriptionYoshitaka Sato, Takahiro Watanabe, Chihiro Suzuki, et al.
Cell Chemical Biology|November 2, 2024
A LANA peptide inhibits tumor growth by inducing CHD4 protein cleavage and triggers cell deathHiroki Miura, Kang-Hsin Wang, Tomoki Inagaki, et al.
Pageof 3